Li Chaoyang, Ford Earl S, McGuire Lisa C, Mokdad Ali H
Centers for Disease Control and Prevention, MS K66, Atlanta, GA 30341, USA.
J Epidemiol Community Health. 2007 Jan;61(1):67-73. doi: 10.1136/jech.2006.048173.
Congestive heart failure (CHF) has been associated with insulin resistance, but few studies have examined its relationship with metabolic syndrome (MetS). Little is known about whether insulin resistance explains the association between MetS and CHF.
Population-based, cross-sectional surveys.
Third National Health and Nutrition Examination Survey (NHANES III).
Data from 5549 men and non-pregnant women aged > or =40 years in NHANES III were analysed.
About 4% of men and 3% of women had CHF between 1988 and 1994 in the US. The age-adjusted prevalence of CHF was significantly higher in African Americans (4.1%), in Mexican Americans (8.5%) and in those of other ethnic origin (6.7%) than in white people (2.5%). People with MetS had nearly twice the likelihood of self-reported CHF (adjusted odds ratio 1.8; 95% confidence interval 1.1 to 3.0) after adjustment for demographic and conventional risk factors such as sex, ethnicity, age, smoking, total cholesterol, left ventricular hypertrophy, and probable or possible myocardial infarction determined by electrocardiography. However, this association was attenuated after further adjustment for insulin resistance as measured by the homoeostasis model assessment (HOMA). >90% of the association between MetS and CHF was explained by the HOMA.
MetS was associated with about a twofold increased likelihood of self-reported CHF and it may serve as a surrogate indicator for the association between insulin resistance and CHF.
充血性心力衰竭(CHF)与胰岛素抵抗有关,但很少有研究探讨其与代谢综合征(MetS)的关系。关于胰岛素抵抗是否能解释MetS与CHF之间的关联,目前知之甚少。
基于人群的横断面调查。
第三次全国健康与营养检查调查(NHANES III)。
分析了NHANES III中5549名年龄≥40岁的男性和非妊娠女性的数据。
1988年至1994年期间,美国约4%的男性和3%的女性患有CHF。经年龄调整后,非裔美国人(4.1%)、墨西哥裔美国人(8.5%)和其他种族(6.7%)的CHF患病率显著高于白人(2.5%)。在对人口统计学和传统风险因素(如性别、种族、年龄、吸烟、总胆固醇、左心室肥厚以及通过心电图确定的可能或疑似心肌梗死)进行调整后,患有MetS的人自我报告CHF的可能性几乎是其他人的两倍(调整后的优势比为1.8;95%置信区间为1.1至3.0)。然而,在通过稳态模型评估(HOMA)测量的胰岛素抵抗进一步调整后,这种关联减弱。MetS与CHF之间>90%的关联可由HOMA解释。
MetS与自我报告CHF的可能性增加约两倍有关,它可能是胰岛素抵抗与CHF之间关联的替代指标。